956 related articles for article (PubMed ID: 26517090)
1. Deregulation of the miR-222-ABCG2 regulatory module in tongue squamous cell carcinoma contributes to chemoresistance and enhanced migratory/invasive potential.
Zhao L; Ren Y; Tang H; Wang W; He Q; Sun J; Zhou X; Wang A
Oncotarget; 2015 Dec; 6(42):44538-50. PubMed ID: 26517090
[TBL] [Abstract][Full Text] [Related]
2. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17A promotes tongue squamous cell carcinoma metastasis through activating miR-23b/versican pathway.
Wei T; Cong X; Wang XT; Xu XJ; Min SN; Ye P; Peng X; Wu LL; Yu GY
Oncotarget; 2017 Jan; 8(4):6663-6680. PubMed ID: 28035060
[TBL] [Abstract][Full Text] [Related]
4. miR-483-5p determines mitochondrial fission and cisplatin sensitivity in tongue squamous cell carcinoma by targeting FIS1.
Fan S; Chen WX; Lv XB; Tang QL; Sun LJ; Liu BD; Zhong JL; Lin ZY; Wang YY; Li QX; Yu X; Zhang HQ; Li YL; Wen B; Zhang Z; Chen WL; Li JS
Cancer Lett; 2015 Jul; 362(2):183-91. PubMed ID: 25843291
[TBL] [Abstract][Full Text] [Related]
5. The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.
Guo J; Jin D; Wu Y; Yang L; Du J; Gong K; Chen W; Dai J; Miao S; Xi S
EBioMedicine; 2018 Sep; 35():204-221. PubMed ID: 30146342
[TBL] [Abstract][Full Text] [Related]
6. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
7. miR-23a promotes cisplatin chemoresistance and protects against cisplatin-induced apoptosis in tongue squamous cell carcinoma cells through Twist.
Peng F; Zhang H; Du Y; Tan P
Oncol Rep; 2015 Feb; 33(2):942-50. PubMed ID: 25501015
[TBL] [Abstract][Full Text] [Related]
8. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
[TBL] [Abstract][Full Text] [Related]
9. miR-181a-Twist1 pathway in the chemoresistance of tongue squamous cell carcinoma.
Liu M; Wang J; Huang H; Hou J; Zhang B; Wang A
Biochem Biophys Res Commun; 2013 Nov; 441(2):364-70. PubMed ID: 24148247
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation.
Chen W; Wang P; Lu Y; Jin T; Lei X; Liu M; Zhuang P; Liao J; Lin Z; Li B; Peng Y; Pan G; Lv X; Zhang H; Ou Z; Xie S; Lin X; Sun S; Ferrone S; Tannous BA; Ruan Y; Li J; Fan S
Theranostics; 2019; 9(20):5739-5754. PubMed ID: 31534516
[TBL] [Abstract][Full Text] [Related]
11. Obovatol inhibits the growth and aggressiveness of tongue squamous cell carcinoma through regulation of the EGF‑mediated JAK‑STAT signaling pathway.
Duan M; Du X; Ren G; Zhang Y; Zheng Y; Sun S; Zhang J
Mol Med Rep; 2018 Aug; 18(2):1651-1659. PubMed ID: 29845251
[TBL] [Abstract][Full Text] [Related]
12. miR-22 regulates cell invasion, migration and proliferation in vitro through inhibiting CD147 expression in tongue squamous cell carcinoma.
Qiu K; Huang Z; Huang Z; He Z; You S
Arch Oral Biol; 2016 Jun; 66():92-7. PubMed ID: 26943814
[TBL] [Abstract][Full Text] [Related]
13. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
[TBL] [Abstract][Full Text] [Related]
14. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of AKT1, a miR-138 target gene, is involved in the migration and invasion of tongue squamous cell carcinoma.
Ji M; Wang W; Yan W; Chen D; Ding X; Wang A
J Oral Pathol Med; 2017 Oct; 46(9):731-737. PubMed ID: 28122142
[TBL] [Abstract][Full Text] [Related]
16. Decreased miR-320a promotes invasion and metastasis of tumor budding cells in tongue squamous cell carcinoma.
Xie N; Wang C; Zhuang Z; Hou J; Liu X; Wu Y; Liu H; Huang H
Oncotarget; 2016 Oct; 7(40):65744-65757. PubMed ID: 27582550
[TBL] [Abstract][Full Text] [Related]
17. BAG3-mediated miRNA let-7g and let-7i inhibit proliferation and enhance apoptosis of human esophageal carcinoma cells by targeting the drug transporter ABCC10.
Wu K; Yang Y; Zhao J; Zhao S
Cancer Lett; 2016 Feb; 371(1):125-33. PubMed ID: 26655271
[TBL] [Abstract][Full Text] [Related]
18. Hyperthermia inhibited the migration of tongue squamous cell carcinoma through TWIST2.
Tang YL; Jiang J; Liu J; Zheng M; He YW; Chen W; Fan YL; Chen QM; Liao CH; Liang XH
J Oral Pathol Med; 2015 May; 44(5):337-44. PubMed ID: 25048179
[TBL] [Abstract][Full Text] [Related]
19. Cancer-associated fibroblasts confer cisplatin resistance of tongue cancer via autophagy activation.
Liao JK; Zhou B; Zhuang XM; Zhuang PL; Zhang DM; Chen WL
Biomed Pharmacother; 2018 Jan; 97():1341-1348. PubMed ID: 29156523
[TBL] [Abstract][Full Text] [Related]
20. SNHG17 enhances the malignant characteristics of tongue squamous cell carcinoma by acting as a competing endogenous RNA on microRNA-876 and thereby increasing specificity protein 1 expression.
Liu X; Zhang B; Jia Y; Fu M
Cell Cycle; 2020 Mar; 19(6):711-725. PubMed ID: 32089063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
